Agonists in Isolated and Perfused Canine Coronary Arteries. Tohoku J. exp. Med., 1986, 150 (2), [145][146][147][148][149][150][151][152][153][154] Regional differences of the responses to adrenoceptor agonists were investigated in isolated canine coronary arteries by use of a cannula inserting method. Acetylcholine induced a dose-dependent vasodilation. Norepinephrine and epinephrine produced a vasoconstriction followed by a strong vasodilation in large coronary arteries and only a weak vasodilation in small coronary arteries. Phenylephrine (a selective alpha-1 agonist) induced a strong vasoconstriction in both arteries. The threshold dose and ED50 value for phenylephrine in small coronary arteries were much larger than those in large coronary arteries, although the vasoconstrictions by KCl and prostaglandin F2a were not different between in large and small coronary arteries. Clonidine and xylazine (selective alpha-2 agonists) produced a slight vasoconstriction but not dosedependently and a vasodilation with extremely large doses. ED50 value of vasodilation for salbutamol (a selective beta-2 agonist) was approximately 80 times greater than that for isoproterenol (a non-selective beta-agonist) in large coronary arteries, but was approximately 20 times in small coronary arteries. The maximal dilator response to salbutamol was about the same as that to isoproterenol in small coronary arteries, whereas it was much smaller than that to isoproterenol in large coronary arteries. These results suggest that adrenoceptors are heterogeneous according to the distance from the coronary orifice in canine epicardial coronary arteries. ----canine coronary artery ; alpha-adrenoceptor ; betaadrenoceptor ; cannula inserting method ; acetylcholine Vasomotion and altered pharmacologic reactivity of the coronary artery are considered to play an important role in coronary circulation, especially ischemic heart disease (Maseri et al. 1978) . Regional variations in reactivities of the human epicardial coronary artery to vasoactive substances were demonstrated in angiographic studies of patients with coronary artery spasm (MacAlpin 1980) . The heterogeneous responses of the coronary arteries to vasoactive agents have been reported in vitro (Zuberbuhler and Bohr 1965 ; Bayer et al. 1974 ; Morishita 1979; Cohen et al. 1983; Miwa and Toda 1984) . However, these studies were commonly performed with helical strips and ring preparations in vitro. Although
there are several studies about the perfusion of the coronary artery segments (Smith 1950; Zuberbuhler and Bohr 1965; Carrier 1965; Trinker 1973; Cornish et al. 1974 ), the regional differences of the responses to vasoactive agents have not been previously investigated by the isolated and perfused coronary artery segments because of difficulty to observe the responses. Hongo and Chiba (1983) developed the new perfusion method (a cannula inserting method), and Tsuji and Chiba (1984) modified it. In this method, vasoactive agents are administered into an intraluminal side of the vessels and the vascular reactions are readily observed changing in perfusion pressure.
In this study, we employed this new method to characterize the pharmacological features of vascular responses to adrenergic agonists and its regional differences in canine isolated and perfused coronary arteries.
MATERIALS AND METHODS
Thirty mongrel dogs of either sex, weighing 5 to 20 kg, were anesthetized with sodium pentobarbital (30 mg/kg, iv.). After treatment with sodium heparin (200 units/kg, iv.), the animals were sacrificed by rapid exsanguination from the right common carotid artery. Thoracotomy was performed in the right forth intercostal space and the heart was rapidly removed. The circumflex branch of the left coronary artery (epicardial portion) was isolated from the heart and cleaned of loose adipose and connective tissues in the cold Krebs-Henseleit solution. The large coronary artery segment (outside diameter [O.D.] 1.5-2.9 mm) was dissected from the proximal portions of the coronary artery. The small coronary artery segment (O.D. 0.7-1.1 mm) was dissected from the distal extramural portions of the coronary artery. The length of the segments were 1-1.5 cm. Large side branches were tied with silk threads. The segment was carefully inserted with a stainlesssteel cannula (0.60-2.65 mm O.D.). The proximal end of the segment was tied to the distal to the hole, and thus the stream from the hole of the cannula passes only through the intraluminal side of the vascular segment (Tsuji and Chiba 1984) . The preparation was perfused with Krebs-Henseleit solution by a peristaltic pump (Harvard Apparatus model 505-1210). The flow rate was kept constant throughout the experiments (approximately 1.5-3 ml/min). The basal perfusion pressure was 40-110 mm Hg in large coronary arteries and 60-150 mm Hg in small coronary arteries. The pressure changes were measured with a pressure transducer (Nikon Kohden AP 621G, Tokyo) and recorded by an ink-writing rectigraph (Nikon Kohden RJG-4028). Vasoconstriction or vasodilation was, therefore, recorded as an increase or a decrease in perfusion pressure, respectively. Krebs-Henseleit solution contained (mM) : NaCI, 118; KCI, 4.7; Mg5O4, 1.2; CaCl2, 2.5; KH2PO4i 1.2; NaHCO3, 25; and glucose, 11 and gassed with 95% 02 and 5% CO2 and maintained at 3TC by a thermopump (Haake EF2, Karls ruhe, FRG). The artery was allowed to equilibrate for about 1 hr until a stable base line was observed before starting experiments.
Drugs used were dl-norepinephrine hydrochloride (NE, Sankyo), dl-epinephrine hydrochloride (Daiichi), l-isoproterenol hydrochloride (Nikken Kagaku), salbutamol hydrochloride (Sankyo), phenylephrine hydrochloride (Kowa), xylazine hydrochloride (Bayer), clonidine hydrochloride (Boehringer Ingelheim), acetylcholine chloride (ACh, Daiichi), prostaglandin F2a (PGF2a, Ono) and potassium chloride. The drug solution was administered into the rubber tube connecting with the cannula in a volume of 10-30 p 1 by a microinjector (Terumo Co., Tokyo) and the injection time was approximately 4 sec.
ED50 was defined as the dose of causing 50% maximal vascular responses to the agonist. The ED50 in this study can not be compared to the values which were calculated in the organ bath experiments. Because drugs were administered into the arteries by a bolus injection in this study.
Results shown in the text and figures are expressed as mean+s.E. Statistical evaluation of the results was performed using Studient's t-test. P values smaller than 0.05 were considered as significant.
RESULTS

Responses to ACh
In canine large coronary arteries, ACh produced only a vasodilation in small doses (below 0.3 jig), but produced a slight vasoconstriction followed by a vasodilation in large doses (Fig, lA) . But ACh induced only a dose-dependent vasodilation in small coronary arteries. The summarized data are shown in Fig. 2 . The threshold dose and ED50 value of vasodilation were about 0.001 jug and 0.38± 0.28 ,u g (n = 9) and those values of vasoconstriction were 0.1 ,u g and 1. 73 + 0.41j g (n = 8) in large coronary arteries, respectively. In small coronary arteries, the threshold dose and ED50 value of vasodilation were about 0.001 jig and 0.63±0.19 ,u g (n6), = respectively.
Responses to PGF2a and KCl
PGF2a induced a vasoconstriction in a dose-related manner. The threshold dose of PGF2a was 0.01-0.03 jug in both small and large coronary arteries and those pinephrine (C), ED50 values were 3.51 + 1.13 jig (n =17) and 3.34±0.58 p g (n 11) in small and large coronary arteries, respectively. The maximal vasoconstriction induced by PGF2a in large coronary arteries was significantly larger than that in small coronary arteries (p <0.05).
KCl also produced dose-related vasoconstrictions in both coronary arteries. The threshold doses were 1 mg in large and 300 jig in small coronary arteries, respectively (Fig. 3) . But ED50 values for KCl were 2.19+0.15 mg (n=24) and 1.76± 0.24 mg (n =13) in small and large coronary arteries, respectively. The maximal constrictor response to KC1 was not different between in large and small coronary arteries.
Responses to NE and epinephrine NE and epinephrine produced a vasodilation following an initial weak vasoconstriction in large coronary arteries (Figs. lB and C), but these agents produced a vasodilation and no constriction in small coronary arteries as summarized in Fig. 4 . The threshold doses for inducing vascular responses by NE and epinephrine were 0.001 to 0.003 ,u g in large coronary arteries, respectively. On the other hand, those in small coronary arteries were 0.0001 jig. ED50 values of vasoconstrictions for NE and epinephrine were 1.58±0.14 ,u g (n = 11) and 0.68± 0.33 p g (n =11), respectively. But the maximal contraction of epinephrine was significantly larger than that of NE in large coronary arteries (p 0.05). ED50 values of vasodilations for NE and epinephrine were 0.29±0.14 jig (n=12) and 2.14 + 0.97 ,u g (n = 9) in large coronary arteries and 0.007 + 0.001, g (n =12) and 0.025 ± 0.008 ,u g (n =12) in small coronary arteries, respectively. Responses to phenylephrine, xylazine and clonidine Phenylephrine (a selective alpha-1 agonist) caused an immediate and dosedependent increase in perfusion pressure (Fig. 1D) . The threshold dose for phenylephrine was approximately 0.001 p g in large and 0.1,u g in small coronary arteries. ED50 values for phenylephrine were approximately 1.20+0.38pg (n= 11) in large and 13.25±5.20 1u g (n =11) in small coronary arteries (Fig. 5) . The maximal response to phenylephrine in small coronary arteries was significantly smaller than those in large coronary arteries (p <0.05).
Xylazine and clonidine (selective alpha-2 agonists) constricted slightly the large (Figs. lE and F) and small coronary arteries in small doses as shown in Fig.  5 . Large doses of these agonists produced a vasodilation followed by a slight vasoconstriction (Fig. 1E) . The responses to xylazine and clonidine in small coronary arteries did not differ from those in large coronary arteries.
Responses to isoproterenol and salbutamol
Isoproterenol (a non-selective beta agonist) and salbutamol (a selective beta-2 agonist) produced only a vasodilation in both coronary arteries. The threshold dose for isoproterenol was below 0.0001 jig, and 0.1p g for salbutamol in large coronary arteries. ED50 values for isoproterenol and salbutamol were 0.085 + 0.035 p g (n = 9) and 6.49± 3.37 p g (n =12) in large coronary arteries, respectively. Those values for isoproterenol and salbutamol were 0.009±0.005 p g (n =10) and 0.199±0.089 p g (n =10) in small coronary arteries, respectively. The maximal response to salbutamol was much smaller than that of isoproterenol in large coronary arteries (p <0.05), whereas that of salbutamol was about the same as that of isoproterenol in small coronary arteries (Fig. 6) .
DISCUSSION
Most studies of coronary vascular reactivities in vitro have been performed by Rubanyi and Vanhoutte (1985) reported the same results. In this study, ACh induced vasodilations without any precontraction whereas that could relax only the precontracted arteries in helical strips and ring preparations (Furchgott and Zawadzki 1980; Rubanyi and Vanhoutte 1985) . The endothelial integrity was confirmed electronmicroscopically (data not shown). We used the isolated coronary arterial preparations which ACh readily induced a marked vasodilation, because the endothelium were intact despite of inserting the stainless-steel cannula into the intraluminal side of the artery. In this study, the maximum vasoconstrictions induced by PGF2a in the small arteries were significantly greater than in the large arteries (p <0.05) and those by KC1 were not different between in the both arteries. But those ED50 values in the small arteries were about the same as in the large arteries. Miwa and Toda (1984) reported that the maximum contractions induced by KC1 were not different between in large and small coronary arteries of dogs and monkeys. The maximum constrictions produced by PGF2a were greater in large coronary arteries than in small coronary arteries of dogs (Cohen et al. 1983 ; Miwa and Toda 1984) . Thus, non-adrenergic constrictions induced by KCl and PGF2a were not different between in small and large coronary arteries. NE and epinephrine produced a biphasic response, i.e., an initial brief vasoconstriction followed by a long-lasting vasodilation in large coronary arteries. On the other hand, these catecholamines usually induced only a vasodilation in small coronary arteries. These results were agreement with the previous reports in the helical strip (Zuberbuhler and Bohr 1965 ; Morishita 1979 ) and the perfusion of large (Trinker 1973 ) and small coronary arteries (Zuberbuhler and Bohr 1965) . There is the possibility that those catecholamines produced no vasoconstriction because of the high perfusion pressure in small coronary arteries. But small coronary arteries were without exception only relaxed by those in even the low basal perfusion pressure (lower than 100 mm Hg). Although we did not use any adrenoceptor antagonist in this study, it is suggested that in small coronary arteries beta-adrenergic activity is predominant and alpha-adrenergic activity is counteracted by beta-adrenergic activity.
In the present study, the threshold doses and apparent ED50 values of vasoconstriction induced by phenylephrine (a selective alpha-1 agonist) in small coronary arteries were significantly larger than those values in large coronary arteries (p <0.05), indicating that alpha-adrenoceptors are sparse in small coronary arteries. The same conclusion was reported in the helical strips of canine coronary arteries (Morishita 1979 ). Phenylephrine did not induce any vasoconstriction in dog and pig small coronary arteries (Bayer et al. 1974; Cohen et al. 1983 ). Those results suggested that the small arteries devoided of functioning alpha-adrenoceptors in isolated dog and pig coronary arteries (Bayer et al. 1974; Cohen et al. 1983 ).
Phenylephrine induced strong contractions whereas clonidine and xylazine produced minimal contractions in canine isolated coronary arteries (this study ; Rimele et al. 1983 ). These findings suggested that postjunctional alphaadrenoceptors may be dominant alpha-1 in canine epicardial coronary arteries as reported past studies (Rimele et al. 1983; Toda et al. 1984 ). On the other hand, postjunctional alpha-2 adrenoceptor mainly mediated the constriction of the resistant vessels in canine hearts perfused in situ (Holtz et al. 1982 ; Heusch et al. 1984; Deussen et al. 1985; Saeed et al. 1985) . Heusch et al. (1984) reported that canine small resistive coronary arteries might be mediated in part by alpha-1 but predominantly alpha-2 adrenoceptors. However, in the present study, clonidine did not induce a significant vasoconstriction in small coronary arteries. Large doses of clonidine and xylazine produced a vasodilation in this study. Clonidine dilated the coronary artery in high concentration (more than 1 x 10-6 M ; Rimele et al. 1983 ). Cocks and Angus (1983) indicated that the stimulation of alpha-2 adrenoceptors could initiate endothelium-dependent relaxation of canine and porcine coronary arteries. Thus, clonidine might dilate the canine coronary arteries mediating by alpha-2 adrenoceptors in this study. To confirm this interpretation, further studies using adrenoceptor antagonists are needed.
ED50 values of vasodilation for salbutamol was approximately 20 and 80 times larger than those for isoproterenol in small and large coronary arteries, respectively. Salbutamol was 3 to 8 times less potent than isoproterenol as a coronary vasodilatation (beta-2) and approximately 80 times less potent than as an inotropic agent (beta-1) in the dog heart (Ross 1974 ). Although we did not use alpha-adrenoceptor antagonists, the order of potency for inducing vasodilation was isoproterenol > > NE > epinephrine > salbutamol in both coronary arteries. Furthermore, the maximal response to salbutamol was about the same as that to isoproterenol in small coronary arteries but not in large coronary arteries. Therefore, salbutamol might act as the full and partial agonists in small and large coronary arteries, respectively. Beta-adrenoceptors seem to be mainly beta-1 in canine epicardial coronary arteries, while they may partially belong to beta-2 in small coronary arteries. The majority of in vitro studies seem to indicate that the coronary vascular adrenoceptors are beta-l, whereas the majority of in vivo investigations indicate that they are beta-2 (Ross i976; Feigl 1983 ). The discrepancy between both studies might mainly reflected the region of coronary arteries, i.e., the in vivo studies mainly reflected the responses of resistance vessels (Ross i976; Feigl 1983 ). Indeed, types of alpha-adrenoceptors are different from conduit and resistant coronary arteries (Heusch et al. 1984 ). Beta-adrenoceptor population did not vary along the course of the isolated coronary artery (0'Donell and Wanstall 1984). There are the regional differences in salbutamol responsiveness despite of using no adrenoceptor antagonist in this study.
In conclusion, this study demonstrates that there are the regional heterogeneities of adrenoceptors in canine epicardial coronary arteries. However, we need further studies using adrenoceptor antagonists in order to confirm the subtypes and those regional heterogeneities of adrenoceptors.
